Navigation Links
Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
Date:8/6/2008

healthcare professional will review your medical history in order to avoid the use of abacavir if you have experienced an allergic reaction to abacavir in the past.

In one study, more patients had a severe hypersensitivity reaction in the abacavir once-daily group than in the abacavir twice-daily group.

ZIAGEN does not cure HIV infection/AIDS or prevent passing HIV to others.

Important Safety Information

ZIAGEN(R) contains abacavir sulfate, which is also contained in EPZICOM (abacavir sulfate and lamivudine) and TRIZIVIR(R) (abacavir sulfate, lamivudine, and zidovudine). Patients taking ZIAGEN may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of having this allergic reaction is much higher if you have a gene variation called HLA*B5701 than if you do not. Your doctor can determine with a blood test if you have this gene variation.

If you get a symptom from 2 or more of the following groups while taking ZIAGEN, stop taking ZIAGEN and call your doctor right away:
1. Fever

2. Rash

3. Nausea, vomiting, diarrhea, or abdominal (stomach area) pain

4. Generally ill feeling, extreme tiredness, or achiness

5. Shortness of breath, cough, or sore throat

Carefully read the Warning Card that your pharmacist gives you and carry it with you at all times.

If you stop ZIAGEN because of an allergic reaction, NEVER take ZIAGEN or any other abacavir-containing medicine (EPZICOM, TRIZIVIR) again. If you take ZIAGEN or any other abacavir-containing medicine again after you have had an allergic reaction, WITHIN HOURS you may get life-threatening symptoms that may include very low blood pressure or death.

If you stop ZIAGEN for any other reason, even for a few days, and you are not allergic to ZIAGEN, talk with your healthcare professional before taking it again. Taking ZIAGEN again can cause a serious or life-threatening reaction, even if you never had a
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... -- Organovo Holdings, Inc. (NYSE MKT: ONVO) today announced preliminary ... year ended March 31, 2015. Based on ... March 31, 2015, Organovo estimates: , Total ... and approximately $571 thousand for the fiscal year , ... and fiscal year ended March 31, 2015 of approximately ...
(Date:4/21/2015)... --Algae International Group, Inc. ( ALGA ), through its ... exceptional Hempster T-Shirt sales following yesterday,s online sales launch. ... introduced four t-shirt designs specific to the ,Hempster Clothing, ... the online sales of these first four t-shirts over ... to the  Marijuana Policy Project  (MPP), an organization dedicated ...
(Date:4/21/2015)... April 21, 2015 Global cap ... World demand for caps and closures will exceed $55 billion ... exceed two trillion annually. Beverages will continue to account for ... and a number of smaller markets are expected to register ... Although the most developed markets -- the US, ...
Breaking Medicine Technology:Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 2Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 3Organovo Holdings, Inc. Pre-Announces Preliminary Fiscal 2015 Fourth Quarter And Year End Financial Information 4American Seed & Oil Company 420 Hempster T-Shirt Sales Soar; Online Sales Launched Yesterday with Start of 420 Week; Over 2000 Shirts Sold So Far 2World Caps & Closures Market 2World Caps & Closures Market 3
(Date:4/21/2015)... Displays & Exhibits, Inc. a division of Absolute ... building industry, announced a management change of the retail ... in Tustin, California.“It is very important to have a ... in quality as offered by overseas trade show accessories ... Adduru is the new manager of Displays & Exhibits ...
(Date:4/21/2015)... Henry Mayo Newhall Hospital, located in California’s ... to automatically send continuation of care documents (CCDs). When ... communication with clinics and other ambulatory practices, they selected ... , “Provider Alert will enable the physician offices ... need to provide continuing care in real time,” said ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 22, 2015 ... Pipeline Review, H1 2015” provides comparative analysis ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report with TOC ... , The report also reviews key players ...
(Date:4/21/2015)... 21, 2015 The report ... comparative analysis on the therapeutic development for ... identifying new targets and MOAs to produce ... TOC is available @ http://www.rnrmarketresearch.com/sinusitis-pipeline-review-h1-2015-market-report.html ... players involved in the therapeutic development for ...
(Date:4/21/2015)... Information is the best weapon in the fight for your ... their families with knowledge about living with cancer in his ... Answer" and new website . , In the book, ... diagnosis through treatment and even death. The goal, he says, ... home and in the examination room. , “Cancer patients and ...
Breaking Medicine News(10 mins):Health News:Displays & Exhibits Reveals Tustin, California Showroom Under New Management 2Health News:Henry Mayo Newhall Hospital to Improve Ambulatory Information Sharing with Summit Healthcare's Summit Provider Alert 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Pulmonary Embolism Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 4Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2
... The following is being issued by Cheryl ... 721 will streamline the health care process for ... long waits and associated, unnecessary costs because they ... treatment."Currently, patients seeking rehabilitation for functional impairments due ...
... experts say, , , THURSDAY, March 5 (HealthDay News) -- Men ... life span by more than two years, Swedish researchers say. ... beneficial effect on length of life as quitting smoking in ... exercise, the researchers said. But Dr. Karl Michaëlsson, a senior ...
... Group, Inc. (OTC Bulletin Board: POLGA ; OTC ... marketer of engineered materials, announced today it will release ... of the market on Wednesday, March 18, 2009. Company ... slides, starting at 10:00 a.m. EDT on Thursday, March ...
... March 5 Despite dermatologists, continual efforts, ... harmful effects of excessive sun exposure and regular use ... to reduce the risk of developing skin cancer. But ... may help encourage them to apply sunscreen regularly via ...
... BRIARCLIFF MANOR, N.Y., March 5 SETO Holdings, Inc. (Pink ... under which it agreed in principle (1) to issue shares ... stock of Advanced Hearing Centers, Inc. ("AHC"), a Maryland corporation ... locations in Maryland and one in Virginia, and (2) to ...
... of infection, study says , , THURSDAY, March 5 (HealthDay News) ... existing vaccines so that they can protect people during a ... ,killer T-cell, is the hit-man of the immune system. It ... body, helping rid us of infections," the study,s lead author, ...
Cached Medicine News:Health News:Men Who Get Active in Midlife Live Longer 2Health News:Men Who Get Active in Midlife Live Longer 3Health News:Polymer Group, Inc. Announces Fourth Quarter and Year-End 2008 Earnings Conference Call 2Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 2Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 3Health News:New Study Finds Text-Messaging Reminders Effective in Improving Adherence to Sunscreen Use 4Health News:SETO Holdings, Inc. Signs Letter of Intent to Dispose of all its Existing Businesses and Acquire Advanced Hearing Centers, Inc.; New Management to be Installed. 2
Used for the introduction of catheters, balloons and other vascular devices....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used for contralateral access to the iliac artery for interventional procedures after initial wire guide positioning has been established....
Used to introduce balloon, electrode, closed or non-tapered end and other catheters....
Medicine Products: